1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIALAviv Pudipeddi, Rupert W. Leong, Simon Ghaly et al.|Gastroenterology|2023Cited by 2
P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trialAviv Pudipeddi, Rupert W. Leong, P Dhanji et al.|Journal of Crohn s and Colitis|2025Cited by 0